These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2480706)

  • 1. Evaluation of antifibrillatory effects of drugs.
    Sugimoto T; Murakawa Y; Toda I
    Am J Cardiol; 1989 Dec; 64(20):33J-36J. PubMed ID: 2480706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
    Murakawa Y; Toda I; Nozaki A; Kawakubo K; Sugimoto T
    Cardiology; 1989; 76(1):58-66. PubMed ID: 2468414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular fibrillation threshold measured by continuous 50 cps stimulation for the evaluation of the antifibrillatory effect of the drugs.
    Toda I; Murakami Y; Nozaki A; Kawakubo K; Sugimoto T
    Jpn Circ J; 1988 Mar; 52(3):249-53. PubMed ID: 3373716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of procainamide on the induction of ventricular fibrillation by sequential ventricular stimulation.
    Murakawa Y; Sugimoto T
    Jpn Circ J; 1987 Feb; 51(2):203-7. PubMed ID: 3599365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cardiac vulnerability and antifibrillatory properties of anti-arrhythmic drugs.
    Smailys A; Gasiunas V; Gasiuniene G
    Resuscitation; 1989 Oct; 18(1):21-30. PubMed ID: 2554443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of procainamide on wave-front dynamics during ventricular fibrillation in open-chest dogs.
    Kwan YY; Fan W; Hough D; Lee JJ; Fishbein MC; Karagueuzian HS; Chen PS
    Circulation; 1998 May; 97(18):1828-36. PubMed ID: 9603538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the effect of bretylium on the ventricular fibrillation threshold in dogs.
    Euler DE; Scanlon PJ
    Am J Cardiol; 1985 May; 55(11):1396-401. PubMed ID: 3993577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flecainide on atrial and ventricular stimulation thresholds to repetitive extrasystoles and fibrillation and on "2nd Phase" ventricular arrhythmias in dogs.
    Heuer H; Gülker H; Thale J; Bender F
    Arzneimittelforschung; 1983; 33(12):1651-4. PubMed ID: 6199033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of antiarrhythmic drugs based on ventricular fibrillation threshold.
    Harumi K; Tsutsumi T; Sato T; Sekiya S
    Am J Cardiol; 1989 Dec; 64(20):10J-14J. PubMed ID: 2480703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual electrophysiologic test for atrial antireentry and ventricular antifibrillatory studies. Effects of bethanidine, procainamide, and WY-48986.
    Wu KM; Hunter TL; Proakis AG
    J Pharmacol Methods; 1990 Apr; 23(2):87-95. PubMed ID: 2332983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrillatory drugs: the case for lidocaine and procainamide.
    White RD
    Ann Emerg Med; 1984 Sep; 13(9 Pt 2):802-4. PubMed ID: 6476546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrillatory effects of class III antiarrhythmic drugs: comparative study with flecainide.
    Usui M; Inoue H; Saihara S; Sugimoto T
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):376-83. PubMed ID: 7681497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiological effects of neferine against ischemic ventricular tachyarrhythmias].
    Guo Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Apr; 20(2):119-22, 134. PubMed ID: 1473481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive extrasystole as an index of vulnerability to ventricular fibrillation.
    Matta RJ; Verrier RL; Lown B
    Am J Physiol; 1976 Jun; 230(6):1469-73. PubMed ID: 59552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The repetitive ventricular response: relationship to ventricular fibrillation threshold in dogs.
    Jones DL; Klein GJ; Gulamhusein S; Jarvis E
    Pacing Clin Electrophysiol; 1983 Nov; 6(6):1258-67. PubMed ID: 6196735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBI-3000 prevents secondary sudden cardiac death.
    Lee JY; Lucchesi BR
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiarrhythmic drugs on the ventricular fibrillation induced by low intensity train pulses.
    Harumi K; Ohta A; Sato T; Yazaki Y; Tsutsumi T
    Jpn Circ J; 1988 Mar; 52(3):243-8. PubMed ID: 3373715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophysiological effects of berbamine on ischemic ventricular tachyarrhythmia].
    Guo ZB; Cao HY; Xu Z; Li Q
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):44-7. PubMed ID: 1950584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.